发明名称 COMPOSITIONS AND THERAPEUTIC METHODS FOR ACCELERATED PLAQUE REGRESSION
摘要 The invention comprises methods for treating and/or preventing cardiovascular, cholesterol, and lipid related disorders, including atherosclerosis, through-co-administration of therapeutically effective amounts of a compound of Formula I or a pharmaceutically acceptable salt thereof and rosuvastatin or pravastatin or a pharmaceutically acceptable salt of rosuvastatin or pitavastatin. The invention further provides compositions comprising a therapeutically effective amount of a compound of Formula I or a pharmaceutically acceptable salt thereof and a therapeutically effective amount of or pitavastatin or a pharmaceutically acceptable salt of rosuvastatin or pitavastatin.
申请公布号 US2016346291(A1) 申请公布日期 2016.12.01
申请号 US201414912517 申请日期 2014.08.21
申请人 LEBIODA Kenneth Eugene 发明人 LEBIODA Kenneth Eugene
分类号 A61K31/5377;A61K31/4375;A61K31/517;A61K31/519;A61K31/505;A61K31/47 主分类号 A61K31/5377
代理机构 代理人
主权项 1. A pharmaceutical composition comprising rosuvastatin or pitavastatin or a pharmaceutically acceptable salt of rosuvastatin or pitavastatin and a compound of Formula I or a pharmaceutically acceptable salt thereof wherein: X is N; Y is CO; R1 and R3 are each independently selected from alkoxy, alkyl, amino, halogen, and hydrogen; R2 is selected from alkoxy, alkyl, alkenyl, alkynyl, amide, amino, halogen, and hydrogen; R6 and R8 are each independently selected from alkyl, alkoxy, amino, halogen, and hydrogen; R5 and R9 are each hydrogen; R7 is selected from amino, amide, alkyl, hydroxyl, and alkoxy; R10 is hydrogen; each W is independently selected from C and N, wherein if W is N, then p is 0 or 1, and if W is C, then p is 1; for W—(R10)p, W is N and p is 1; for W—(R7)p, W is C and p is 1; for W—(R4)p, W is C, p is 1 and R4 is H, or W is N and p is 0; for (R1)p, p is 1; for (R2)p, p is 1; for (R3)p, p is 1; for (R6)p, p is 1; for (R8)p, p is 1; for (R9)p, p is 1; Z1 is a double bond, and Z2 and Z3 are each a single bond; with the proviso that if R1 is hydrogen, then R3 is alkoxy; with the proviso that if R3 is hydrogen, then R1 is selected from amino and alkoxy; with the proviso that if R7 is selected from alkyl, hydroxyl, and alkoxy, then at least one of R6 and R8 is independently selected from alkyl, alkoxy, amino, and halogen.
地址 US
您可能感兴趣的专利